Geode Capital Management, LLC P Lx Pharma Inc. Transaction History

Geode Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.15 - $0.63 $2,004 - $8,417	-13,361 Reduced 5.33%	237,491 $38,000
Q3 2022 Nov 14, 2022	BUY	$0.52 - $3.08 $3,574 - $21,171	6,874 Added 2.82%	250,852 $163,000
Q2 2022 Aug 12, 2022	BUY	$1.9 - $4.18 $12,876 - $28,327	6,777 Added 2.86%	243,978 $592,000
Q1 2022 May 13, 2022	BUY	$3.54 - $8.3 $74,478 - $174,623	21,039 Added 9.73%	237,201 $958,000
Q3 2021 Nov 12, 2021	BUY	$12.22 - $21.28 $187,222 - $326,030	15,321 Added 7.63%	216,162 $4.17 Million
Q2 2021 Aug 13, 2021	BUY	$9.0 - $15.94 $345,105 - $611,219	38,345 Added 23.6%	200,841 $2.77 Million
Q1 2021 May 12, 2021	BUY	$5.24 - $10.14 $851,479 - $1.65 Million	162,496 New	162,496 $1.47 Million

62.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.